Загрузка страницы
Все видеоНовые видеоПопулярные видеоКатегории видео

Regeneron begins COVID-19 antibody therapy testing

Regeneron is beginning testing for an antibody cocktail designed as a treatment for the coronavirus. Regeneron President & Chief Scientific Officer Dr. George Yancopoulos joins Yahoo Finance’s Melody Hahm and Anjalee Khemlani to discuss.
#COVID19 #coronavirus #covid19antibody
Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb

About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Connect with Yahoo Finance:
Get the latest news: https://yhoo.it/2fGu5Bb
Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq
Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP
Follow Yahoo Finance on Instagram: http://bit.ly/2LOpNYz

Видео Regeneron begins COVID-19 antibody therapy testing канала Yahoo Finance
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
16 июня 2020 г. 2:00:39
00:09:08
Yahoo Finance
Теги
Правообладателям
Жалоба
Комментарии
Другие видео канала
Coronavirus Treatment and Prevention With Monoclonal AntibodiesCoronavirus Treatment and Prevention With Monoclonal AntibodiesHuman monoclonal antibodies as therapeutics against viral and bacterial infectionsHuman monoclonal antibodies as therapeutics against viral and bacterial infectionsLower-Dose Regeneron Antibody Cocktail Is 'Game-Changing': CSOLower-Dose Regeneron Antibody Cocktail Is 'Game-Changing': CSOCoronavirus Pandemic Update 94: Inhaled Steroids COVID-19 Treatment; New Pneumonia in Kazakhstan?Coronavirus Pandemic Update 94: Inhaled Steroids COVID-19 Treatment; New Pneumonia in Kazakhstan?Regeneron Antibody Cocktail (Trump COVID-19)Regeneron Antibody Cocktail (Trump COVID-19)Aflac’s duck commercials ‘doubled its business in three years’: Dan AmosAflac’s duck commercials ‘doubled its business in three years’: Dan AmosRegeneron Stock Analysis – $REGN does a lot more than COVID-19 drug development.Regeneron Stock Analysis – $REGN does a lot more than COVID-19 drug development.Coronavirus Update 117: Moderna vs. Pfizer COVID 19 Vaccine (mRNA vaccines)Coronavirus Update 117: Moderna vs. Pfizer COVID 19 Vaccine (mRNA vaccines)Monoclonal antibody therapy for COVID19 - Regeneron and Eli Lilly (#36)Monoclonal antibody therapy for COVID19 - Regeneron and Eli Lilly (#36)This fast-food chain is paying some teens $50K amid labor shortagesThis fast-food chain is paying some teens $50K amid labor shortagesCure for COVID-19? The drug that has killed Coronavirus in the test tube | 60 Minutes AustraliaCure for COVID-19? The drug that has killed Coronavirus in the test tube | 60 Minutes AustraliaImmune 29: Immunology of COVID-19Immune 29: Immunology of COVID-19COVID-19 Insights: Monoclonal AntibodiesCOVID-19 Insights: Monoclonal AntibodiesIf You Get COVID 19: Optimize Immune System (Vitamin D, Monoclonal Antibodies, NAC, Quercetin etc.)If You Get COVID 19: Optimize Immune System (Vitamin D, Monoclonal Antibodies, NAC, Quercetin etc.)COVID-19 Antibodies: Why is Everyone Testing Negative? - NEW DATACOVID-19 Antibodies: Why is Everyone Testing Negative? - NEW DATACarlos Santana. Europe. Guitar Cover (Fingerstyle)Carlos Santana. Europe. Guitar Cover (Fingerstyle)Moderna CEO Stephane Bancel on the Race for a Covid-19 VaccineModerna CEO Stephane Bancel on the Race for a Covid-19 VaccineCOVID 19 Treatment by Dr Ankit Kumar DAMS FacultyCOVID 19 Treatment by Dr Ankit Kumar DAMS FacultyAntibodies Against COVID-19: The Path to Effective Treatments and a VaccineAntibodies Against COVID-19: The Path to Effective Treatments and a VaccineRobert Kennedy Jr. on 'Controversial' Vaccines, Trump, and climate changeRobert Kennedy Jr. on 'Controversial' Vaccines, Trump, and climate change
Статистика портала
Яндекс.Метрика
© 2008-2024 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения
salda.ws salda.ws@mail.ru
Сейчас на сайте: 512 Статистика портала